Previous Article | Next Article ![]()
Infection and Immunity, July 2001, p. 4486-4492, Vol. 69, No. 7
Department of Microbiology, University of
Alabama at Birmingham, Birmingham, Alabama
352941 and Center for Microbial
Pathogenesis and Department of Microbiology, School of Medicine and
Biomedical Sciences, State University of New York at Buffalo, Buffalo,
New York 142142
Received 1 February 2001/Returned for modification 30 March
2001/Accepted 9 April 2001
Cholera toxin (CT) and the type II heat-labile enterotoxins (HLT)
LT-IIa and LT-IIb act as potent systemic and mucosal adjuvants and
induce distinct T-helper (Th)-cell cytokine profiles. In the present
study, CT and the type II HLT were found to differentially affect
cytokine production by anti-CD3-stimulated human peripheral blood
mononuclear cells (PBMC), and the cellular mechanisms responsible were
investigated. CT suppressed interleukin-2 (IL-2), tumor necrosis factor
alpha (TNF-
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.7.4486-4492.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Distinct Cytokine Regulation by Cholera Toxin and
Type II Heat-Labile Toxins Involves Differential Regulation of CD40
Ligand on CD4+ T Cells
), and IL-12 production by PBMC cultures more than either
LT-IIa or LT-IIb. CT but not LT-IIa or LT-IIb reduced the expression of
CD4+ T-cell surface activation markers (CD25 and CD69) and
subsequent proliferative responses of anti-CD3-stimulated T cells. CT
but not LT-IIa or LT-IIb significantly reduced the expression of CD40 ligand (CD40L) on CD4+ T cells. In a coculture system,
CT-treated CD4+ T cells induced significantly less TNF-
and IL-12 p70 production by both autologous monocytes and
monocyte-derived dendritic cells than either LT-IIa- or LT-IIb-treated
CD4+ T cells. These findings demonstrate that CT, LT-IIa,
and LT-IIb differentially affect CD40-CD40L interactions between
antigen-presenting cells and T cells and help explain the distinct
cytokine profiles observed with type I and type II HLT when used as
mucosal adjuvants.
*
Corresponding author. Mailing address: Department of
Microbiology, University of Alabama at Birmingham, 845 South 19th, BBRB 634, Birmingham, AL 35294-2170. Phone: (205) 934-3033. Fax: (205) 934-3894. E-mail: michmart{at}uab.edu.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»